Niamh Pellegrini

Niamh Pellegrini

Directeur/Membre du Conseil chez ACUTUS MEDICAL, INC.

Fortune : - $ au 31/05/2026

59 ans
Health Technology
Finance
Consumer Services

Profil

Niamh Louise Pellegrini currently works at Acutus Medical, Inc., as Independent Director from 2021.
Ms. Pellegrini also formerly worked at Autonomic Technologies, Inc., as President, Chief Executive Officer & Director from 2016 to 2018, ViaCyte, Inc., as Director, NeoTract, Inc., as Director, Johnson & Johnson, as Principal, Thoratec Corp., as President-North American Operations from 2014 to 2015, Johnson & Johnson Innovation - JJDC, Inc., as Vice President from 2009 to 2010, Lifescan, Inc., as Principal, Nevro Corp., as Chief Commercial Officer & Senior Vice President from 2019 to 2023, and Abbott Vascular, Inc., as Vice President-Global Commercial Operations from 2018 to 2019.
Ms. Pellegrini received her undergraduate degree and Masters Business Admin degree from Santa Clara University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/02/2025 20 972 ( 0,07% ) - $ 31/05/2026

Postes actifs de Niamh Pellegrini

SociétésPosteDébut
ACUTUS MEDICAL, INC. Directeur/Membre du Conseil 10/08/2021

Anciens postes connus de Niamh Pellegrini

SociétésPosteFin
NEVRO CORP. Corporate Officer/Principal 09/06/2023
Corporate Officer/Principal 01/06/2019
Directeur Général 01/06/2018
THORATEC CORPORATION Corporate Officer/Principal 08/10/2015
Private Equity Investor 30/03/2010
Voir l'expérience en détail de Niamh Pellegrini

Formation de Niamh Pellegrini

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

35

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Niamh Pellegrini
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT